BlackRock Group’s Foundation Medicine, Inc. FMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$72K Buy
4,021
+399
+11% +$8.6K ﹤0.01% 2879
2016
Q3
$85K Buy
3,622
+171
+5% +$3.88K ﹤0.01% 2843
2016
Q2
$65K Sell
3,451
-57
-2% -$1.03K ﹤0.01% 2879
2016
Q1
$63K Buy
3,508
+1,349
+62% +$21.7K ﹤0.01% 2876
2015
Q4
$46K Sell
2,159
-37,218
-95% -$717K ﹤0.01% 2834
2015
Q3
$726K Buy
39,377
+482
+1% +$12K ﹤0.01% 2058
2015
Q2
$1.32M Buy
38,895
+12,974
+50% +$522K ﹤0.01% 1792
2015
Q1
$1.25M Sell
25,921
-31,177
-55% -$1.41M ﹤0.01% 1748
2014
Q4
$1.27M Buy
57,098
+56,446
+8,657% +$1.3M ﹤0.01% 1744
2014
Q3
$12K Sell
652
-14,836
-96% -$354K ﹤0.01% 2800
2014
Q2
$418K Buy
+15,488
New +$393K ﹤0.01% 2272

Other funds holding FMI

BlackRock Group's FMI Position: Q4 2016 in Review

BlackRock Group increased its Foundation Medicine, Inc. (FMI) stake by 11% in Q4 2016, buying an estimated $8.6K and bringing the position to 4,021 shares worth $72K. The position accounts for ﹤0.01% of the portfolio, ranked #2879.

BlackRock Group first reported a position in FMI in Q2 2014 and has held it in 11 quarters since. The position peaked at $1.32M in Q2 2015. 95 funds tracked by Wall St. Rank hold FMI as of Q4 2016.

  • BlackRock Group held 4,021 shares of Foundation Medicine, Inc. worth $72K as of Q4 2016.
  • BlackRock Group bought 399 Foundation Medicine, Inc. shares in Q4 2016, an estimated $8.6K.
  • Foundation Medicine, Inc. made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2879 holding.
  • BlackRock Group first reported a position in Foundation Medicine, Inc. in Q2 2014 and has held it in 11 quarters since.
  • BlackRock Group's Foundation Medicine, Inc. position peaked at $1.32M in Q2 2015.
  • 95 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.